| Participating cities | ||
---|---|---|---|
Specialist palliative care service | London | Dublin | New York |
Hospital palliative care team(s) providing a consultative service | Medical Attendings/Consultants, fellows/trainee doctors, clinical nurse specialists/practitioners, psychosocial/social workers, administrative support | Medical Attendings/Consultants, fellows/trainee doctors, clinical nurse specialists/practitioners, psychosocial/social workers, administrative support | Medical Attendings/Consultants, fellows/trainee doctors, clinical nurse specialists/practitioners |
Inpatient palliative care unit within service | No | No | Yes, 10 beds |
Extended team | Chaplaincy, pharmacy | Pharmacy, physiotherapy, chaplaincy | Social workers, chaplaincy, fellows/trainee doctors, triage nurse |
Outpatient clinics | Yes | Yes | Yes |
Community palliative care team | Yes (part of catchment area) | No | Yes |
On call for specialist advice and emergencies | Yes | Yes | Yes |
On call weekend ward rounds | Yes | No | Yes |
Co-operation with local hospicesa | Yes | Yes | Yes |
Funding | Paid for by a tariff specifically for activity as part of National Health Service within the hospitals, local inpatient services in hospices paid for by mix of charity and National Health Service. Additional charitable support for components. | Paid for as part of historic block grant allocation as part of National Health Service within the hospitals. Additional charitable support for components. | Program is funded through physician and advance practice nurse billing under Medicare Part B, the Mount Sinai Hospital through Medicare Part A revenues, and contributions from private sector philanthropy. |
Annual referrals to services (all ages) at time of study, % >65Â years, % with cancer. | 1450 Annual referrals (KCH) 70% aged over 65Â years 35% Cancer, 65% Non cancer | 1370 Annual referrals (MMUH + Beaumont) 74% aged over 65Â years 65% Cancer, 35% Non cancer | 2175 Annual referrals (consultation service) 57% aged over 65Â years 34% Cancer, 66% Non cancer |